1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25 | Licensing Program Analyst (LPA) Angela Barutyan conducted a Case Management - Deficiencies visit in conjunction with a complaint visit (Complaint Control # 29-AS-20240822111237). The purpose of the visit is to issue citations for a deficiency observed during the initial complaint investigation.
During the visit on 08/28/2024, LPA Barutyan and North Los Angeles County Regional Center (NLACRC), Quality Assurance Specialists (QASs) Lisseth Carrillo and Miguel Aguilar observed four (4) medication errors during medication review between 11:30AM-12:30PM. During medication review for Client 1 (C1), it was observed that the medication Almacone was logged as administered two (2) times on 08/22/2024 at 3PM and 8PM, however, Almacone was logged as administered twice on 08/21/2024 on the medication administration record. The 8PM entry for the medication was observed crossed out with pen. The medication Loperamide was logged as administered three (3) times, two (2) times on 08/22/2024 and one (1) time on 08/24/2024 but was logged on the medication administration record as one (1) time on 08/22/2024 and one (1) time on 08/24/2024. It was observed that C1 has a daily prescription medication, Senna and Docusate, for constipation. Further review of the medication information pamphlet revealed that the medication should not be administered if there has been a change in bowel movements for longer than two (2) weeks, which C1 has been experiencing.
The following deficiency was observed (See LIC 809-D.) and cited from the California Code of Regulations, Title 22 and California Health and Safety Code. Failure to correct the deficiency may result in civil penalties.
Exit interview was conducted. A copy of the report and appeal rights were provided.
|